Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2017

19.06.2017 | Maternal-Fetal Medicine

Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation

verfasst von: Scott A. Shainker, Katelyn Dannheim, Kristin D. Gerson, Dayna Neo, Zsuzsanna K. Zsengeller, Elizabeth Pernicone, S. Ananth Karumanchi, Michele R. Hacker, Jonathan L. Hecht

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To confirm reduced expression of soluble fms-like tyrosine kinase 1 (sFlt-1) in accreta/increta.

Methods

Formalin-fixed tissue sections from 11 peripartum hysterectomies with invasive placentation and 5 controls were stained for sFlt-1. Stain intensity was scored in selected 100× microscopic fields. We compared sFlt-1 expression in invasive areas among cases, non-invasive areas among cases and areas from control placentas.

Results

Chorionic villi displayed significantly decreased sFlt-1 expression in invasive areas of cases compared to control placentas (p = 0.003), as well as in non-invasive areas of cases compared to control placentas (p = 0.01). There was no difference in sFlt-1 expression between invasive and non-invasive areas among cases.

Conclusions

Expression of sFlt-1 is diminished in villous trophoblasts from patients with placenta increta or percreta. Local depth of invasion was not associated with sFlt-1 expression, suggesting a more global abnormality across the implantation site rather than localized to areas of histologic invasion.
Literatur
1.
Zurück zum Zitat Creanga AA, Bateman BT, Butwick AJ, Raleigh L, Maeda A, Kuklina E, Callaghan WM (2015) Morbidity associated with cesarean delivery in the united states: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol 213:384. doi:10.1016/j.ajog.2015.05.002 (e381-311) CrossRefPubMed Creanga AA, Bateman BT, Butwick AJ, Raleigh L, Maeda A, Kuklina E, Callaghan WM (2015) Morbidity associated with cesarean delivery in the united states: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol 213:384. doi:10.​1016/​j.​ajog.​2015.​05.​002 (e381-311) CrossRefPubMed
3.
Zurück zum Zitat Baltajian K, Hecht JL, Wenger JB, Salahuddin S, Verlohren S, Perschel FH, Zsengeller ZK, Thadhani R, Karumanchi SA, Rana S (2014) Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy 33:427–439. doi:10.3109/10641955.2014.926914 CrossRefPubMed Baltajian K, Hecht JL, Wenger JB, Salahuddin S, Verlohren S, Perschel FH, Zsengeller ZK, Thadhani R, Karumanchi SA, Rana S (2014) Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy 33:427–439. doi:10.​3109/​10641955.​2014.​926914 CrossRefPubMed
4.
Zurück zum Zitat Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658. doi:10.1172/JCI17189 CrossRefPubMedPubMedCentral Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658. doi:10.​1172/​JCI17189 CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat McMahon K, Karumanchi SA, Stillman IE, Cummings P, Patton D, Easterling T (2014) Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. Am J Obstet Gynecol 210(68):e61–e64. doi:10.1016/j.ajog.2013.08.032 McMahon K, Karumanchi SA, Stillman IE, Cummings P, Patton D, Easterling T (2014) Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. Am J Obstet Gynecol 210(68):e61–e64. doi:10.​1016/​j.​ajog.​2013.​08.​032
7.
Zurück zum Zitat Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM, Karumanchi SA (2012) Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 59:256–264. doi:10.1161/HYPERTENSIONAHA.111.182170 CrossRefPubMedPubMedCentral Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM, Karumanchi SA (2012) Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 59:256–264. doi:10.​1161/​HYPERTENSIONAHA.​111.​182170 CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, Dhal S, Agrawal R, Sutton RE, Druzin ML, Gambhir SS, Ambati BK, Cross JC, Nayak NR (2014) Endometrial vegf induces placental sflt1 and leads to pregnancy complications. J Clin Invest 124:4941–4952. doi:10.1172/JCI76864 CrossRefPubMedPubMedCentral Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, Dhal S, Agrawal R, Sutton RE, Druzin ML, Gambhir SS, Ambati BK, Cross JC, Nayak NR (2014) Endometrial vegf induces placental sflt1 and leads to pregnancy complications. J Clin Invest 124:4941–4952. doi:10.​1172/​JCI76864 CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Tseng JJ, Chou MM, Hsieh YT, Wen MC, Ho ES, Hsu SL (2006) Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta 27:70–78. doi:10.1016/j.placenta.2004.12.011 CrossRefPubMed Tseng JJ, Chou MM, Hsieh YT, Wen MC, Ho ES, Hsu SL (2006) Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta 27:70–78. doi:10.​1016/​j.​placenta.​2004.​12.​011 CrossRefPubMed
10.
Zurück zum Zitat Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by hif-1. Am J Physiol Regul Integr Comp Physiol 291:R1085–R1093. doi:10.1152/ajpregu.00794.2005 CrossRefPubMed Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by hif-1. Am J Physiol Regul Integr Comp Physiol 291:R1085–R1093. doi:10.​1152/​ajpregu.​00794.​2005 CrossRefPubMed
12.
Zurück zum Zitat Biswas R, Sawhney H, Dass R, Saran RK, Vasishta K (1999) Histopathological study of placental bed biopsy in placenta previa. Acta Obstet Gynecol Scand 78:173–179CrossRefPubMed Biswas R, Sawhney H, Dass R, Saran RK, Vasishta K (1999) Histopathological study of placental bed biopsy in placenta previa. Acta Obstet Gynecol Scand 78:173–179CrossRefPubMed
13.
Zurück zum Zitat Taki A, Abe M, Komaki M, Oku K, Iseki S, Mizutani S, Morita I (2012) Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom (Kyoto) 52:97–103. doi:10.1111/j.1741-4520.2012.00359.x CrossRef Taki A, Abe M, Komaki M, Oku K, Iseki S, Mizutani S, Morita I (2012) Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom (Kyoto) 52:97–103. doi:10.​1111/​j.​1741-4520.​2012.​00359.​x CrossRef
16.
Zurück zum Zitat Lyell DJ, Faucett AM, Baer RJ, Blumenfeld YJ, Druzin ML, El-Sayed YY, Shaw GM, Currier RJ, Jelliffe-Pawlowski LL (2015) Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol 35:570–574. doi:10.1038/jp.2015.40 CrossRefPubMed Lyell DJ, Faucett AM, Baer RJ, Blumenfeld YJ, Druzin ML, El-Sayed YY, Shaw GM, Currier RJ, Jelliffe-Pawlowski LL (2015) Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol 35:570–574. doi:10.​1038/​jp.​2015.​40 CrossRefPubMed
17.
Zurück zum Zitat Thompson O, Otigbah C, Nnochiri A, Sumithran E, Spencer K (2015) First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation. BJOG 122:1370–1376. doi:10.1111/1471-0528.13298 CrossRefPubMed Thompson O, Otigbah C, Nnochiri A, Sumithran E, Spencer K (2015) First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation. BJOG 122:1370–1376. doi:10.​1111/​1471-0528.​13298 CrossRefPubMed
19.
Zurück zum Zitat Collins SL, Stevenson GN, Al-Khan A, Illsley NP, Impey L, Pappas L, Zamudio S (2015) Three-dimensional power doppler ultrasonography for diagnosing abnormally invasive placenta and quantifying the risk. Obstet Gynecol 126:645–653. doi:10.1097/AOG.0000000000000962 CrossRefPubMed Collins SL, Stevenson GN, Al-Khan A, Illsley NP, Impey L, Pappas L, Zamudio S (2015) Three-dimensional power doppler ultrasonography for diagnosing abnormally invasive placenta and quantifying the risk. Obstet Gynecol 126:645–653. doi:10.​1097/​AOG.​0000000000000962​ CrossRefPubMed
20.
Zurück zum Zitat Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ (1999) Inhibition of tgf-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103:1641–1650. doi:10.1172/JCI6380 CrossRefPubMedPubMedCentral Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ (1999) Inhibition of tgf-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103:1641–1650. doi:10.​1172/​JCI6380 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405–1423. doi:10.1016/S0002-9440(10)62567-9 CrossRefPubMedPubMedCentral Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405–1423. doi:10.​1016/​S0002-9440(10)62567-9 CrossRefPubMedPubMedCentral
Metadaten
Titel
Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation
verfasst von
Scott A. Shainker
Katelyn Dannheim
Kristin D. Gerson
Dayna Neo
Zsuzsanna K. Zsengeller
Elizabeth Pernicone
S. Ananth Karumanchi
Michele R. Hacker
Jonathan L. Hecht
Publikationsdatum
19.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4432-7

Weitere Artikel der Ausgabe 2/2017

Archives of Gynecology and Obstetrics 2/2017 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.